Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000658584 | SCV000780361 | uncertain significance | not provided | 2018-02-28 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173108 | SCV001336184 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Invitae | RCV001227298 | SCV001399650 | uncertain significance | Charcot-Marie-Tooth disease type 4 | 2019-10-03 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with glutamine at codon 1289 of the SBF2 protein (p.Arg1289Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs757836523, ExAC 0.02%). This variant has not been reported in the literature in individuals with SBF2-related conditions. ClinVar contains an entry for this variant (Variation ID: 546658). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |